Oppenheimer Analyst Christopher Mara Says Sarepta Therapeutic Entered Quiet Period Friday, Indicating Analysis/Submission Of Dystrophin Data From 48-Week Biopsies Of 13 PRMOOVI Patients From FDA Is Imminent

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!

  • The most trusted brand in stock market news
  • Fatest intelligence & alerts
  • Active trader chat rooms
  • Option trade alerts
  • Only comprehensive mobile notifications solution
  • Welcoming & white glove support
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorNewsFDAAnalyst Ratings
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...